PLoS ONE, 2011 · DOI: 10.1371/journal.pone.0017126 · Published: March 18, 2011
This study investigates a new approach to treating spinal cord injuries by transplanting embryonic stem cells that have been modified to produce more of a protein called L1. These modified cells, called L1 overexpressing SENAs, are designed to help nerve cells survive and grow in the damaged spinal cord environment. The results showed that mice receiving these modified cells had better movement and nerve regeneration compared to those receiving regular stem cells or a control treatment.
Embryonic stem cells, particularly when genetically modified with L1, hold promise for early therapy after spinal cord injury.
L1 overexpression in the microenvironment of the lesioned spinal cord is a novel finding that could make it more attractive for pre-clinical studies in spinal cord regeneration.
L1's functions may extend to other diseases of the nervous system, warranting further investigation.